BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7759725)

  • 1. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).
    Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB
    J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.
    Abdelmeguid AE; Topol EJ; Whitlow PL; Sapp SK; Ellis SG
    Circulation; 1996 Oct; 94(7):1528-36. PubMed ID: 8840840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I).
    Elliott JM; Berdan LG; Holmes DR; Isner JM; King SB; Keeler GP; Kearney M; Califf RM; Topol EJ
    Circulation; 1995 Apr; 91(8):2158-66. PubMed ID: 7697844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
    Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ
    J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I).
    Omoigui NA; Califf RM; Pieper K; Keeler G; O'Hanesian MA; Berdan LG; Mark DB; Talley JD; Topol EJ
    J Am Coll Cardiol; 1995 Oct; 26(4):922-30. PubMed ID: 7560619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions.
    Abdelmeguid AE; Ellis SG; Sapp SK; Whitlow PL; Topol EJ
    Am Heart J; 1996 Jun; 131(6):1097-105. PubMed ID: 8644587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myonecrosis after revascularization procedures.
    Califf RM; Abdelmeguid AE; Kuntz RE; Popma JJ; Davidson CJ; Cohen EA; Kleiman NS; Mahaffey KW; Topol EJ; Pepine CJ; Lipicky RJ; Granger CB; Harrington RA; Tardiff BE; Crenshaw BS; Bauman RP; Zuckerman BD; Chaitman BR; Bittl JA; Ohman EM
    J Am Coll Cardiol; 1998 Feb; 31(2):241-51. PubMed ID: 9462562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure.
    Abdelmeguid AE; Whitlow PL; Sapp SK; Ellis SG; Topol EJ
    Circulation; 1995 Jun; 91(11):2733-41. PubMed ID: 7758178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directional atherectomy versus balloon angioplasty for coronary ostial and nonostial left anterior descending coronary artery lesions: results from a randomized multicenter trial. The CAVEAT-I investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Boehrer JD; Ellis SG; Pieper K; Holmes DR; Keeler GP; Debowey D; Chapekis AT; Leya F; Mooney MR; Gottlieb RS
    J Am Coll Cardiol; 1995 May; 25(6):1380-6. PubMed ID: 7722137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty.
    Klein LW; Kramer BL; Howard E; Lesch M
    J Am Coll Cardiol; 1991 Mar; 17(3):621-6. PubMed ID: 1993778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnosis of myocardial damage during coronary angioplasty by the analysis of the isoforms of the enzyme creatine kinase MB].
    Vázquez Rodríguez JM; Hossein-Nia M; Chester M; Leatham E; Holt DW; Kaski JC
    Rev Esp Cardiol; 1995 Aug; 48(8):528-36. PubMed ID: 7644806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Holmes DR; Simpson JB; Berdan LG; Gottlieb RS; Leya F; Keeler GP; Califf RM; Topol EJ
    J Am Coll Cardiol; 1995 Nov; 26(6):1494-500. PubMed ID: 7594076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trials of directional coronary atherectomy: implications for clinical practice and future investigation.
    Holmes DR; Topol EJ; Adelman AG; Cohen EA; Califf RM
    J Am Coll Cardiol; 1994 Aug; 24(2):431-9. PubMed ID: 8034880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty.
    Ohnishi N; Iwasaki K; Kusachi S; Hirami R; Matano S; Ohnishi H; Takeda K; Kita T; Sakakibara N; Tsuji T
    Jpn Heart J; 1998 Mar; 39(2):139-46. PubMed ID: 9687822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.
    Ioannidis JP; Karvouni E; Katritsis DG
    J Am Coll Cardiol; 2003 Oct; 42(8):1406-11. PubMed ID: 14563583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.